Javascript must be enabled to continue!
GW24-e2411 Circulating miR-499 associated with perioperative myocardial injury after coronary artery bypass graft surgery
View through CrossRef
Objectives
MicroRNAs (miRNAs) play key roles in diverse biological and pathological processes, including the regulation of proliferation, apoptosis and cellular differentiation. Recently, circulating miRNAs have been proposed as potential biomarkers for cardiovascular disease. However, its value in the evaluation of perioperative myocardial injury has not yet been assessed. In the present study, we presumed that plasma concentrations of miR-499 may serve as a biomarker for identifying myocardial injury in cardiac surgery.
Methods
Thirty two consecutive patients undergoing on pump coronary artery bypass grafting (CABG)were included in a prospective, randomised study using standardised operative procedures and myocardial protection. Serial plasma samples from patients were collected at 7 perioperative time points (preoperatively, 1, 3, 6, 12, 24, 48 h after declamping), and were tested for miRNAs and cardiac troponin I (cTnI). Total RNA were extracted from plasma with mirVana PARIS Kit. The levels of circulating musle-specific miR-499 were measured by TaqMan quantitative reverse transcription-PCR (qRT-PCR),and plasma cTnI concentrations were measured by electrochemiluminescence based methods on the Beckman ACCESS2 Analyser.
Results
Our study showed that circulating miR-499 was highly elevated at 1, 3, 6h after declamping in CABG patients, 50-fold (P < 0.01), 100-fold (P < 0.01),and 50-fold (P < 0.01), respectively, as compared with the preoperative. And it gradually returned closer to normal at 48h (6-fold; P < 0.01). MiR-499 and cTnI exhibited the same trend. Importantly, miR-499 levels peaked as early as 1 h after declamping, whereas TnI peaked only 6 h after declamping. Indeed, peak plasma levels of miR-499 correlated significantly with peak level of cTnI (r = 0.648, P = 0.001), indicating the degree of myocardial damage.
Conclusions
In this study, we reported the expression of circulating miR-499 in CABG. In comparison to the preoperative, interestingly, miR-499 plasma levels in patients with CABG up-regulated after the declamping. Importantly, an outstanding finding in this study is that miR-499 and cTnI exhibited the same trend. The plasma concentration of miR-499 showed a good correlation with the plasma concentration of cTnI, a classic marker of myocardial injury. The plasma concentration of miR-499 can be a potential indicator of myocardial injury in CABG. Thus, our results clearly hold out the hypothesis that miR-499 may be useful for identifying perioperative myocardial injury in CABG patients.
Title: GW24-e2411 Circulating miR-499 associated with perioperative myocardial injury after coronary artery bypass graft surgery
Description:
Objectives
MicroRNAs (miRNAs) play key roles in diverse biological and pathological processes, including the regulation of proliferation, apoptosis and cellular differentiation.
Recently, circulating miRNAs have been proposed as potential biomarkers for cardiovascular disease.
However, its value in the evaluation of perioperative myocardial injury has not yet been assessed.
In the present study, we presumed that plasma concentrations of miR-499 may serve as a biomarker for identifying myocardial injury in cardiac surgery.
Methods
Thirty two consecutive patients undergoing on pump coronary artery bypass grafting (CABG)were included in a prospective, randomised study using standardised operative procedures and myocardial protection.
Serial plasma samples from patients were collected at 7 perioperative time points (preoperatively, 1, 3, 6, 12, 24, 48 h after declamping), and were tested for miRNAs and cardiac troponin I (cTnI).
Total RNA were extracted from plasma with mirVana PARIS Kit.
The levels of circulating musle-specific miR-499 were measured by TaqMan quantitative reverse transcription-PCR (qRT-PCR),and plasma cTnI concentrations were measured by electrochemiluminescence based methods on the Beckman ACCESS2 Analyser.
Results
Our study showed that circulating miR-499 was highly elevated at 1, 3, 6h after declamping in CABG patients, 50-fold (P < 0.
01), 100-fold (P < 0.
01),and 50-fold (P < 0.
01), respectively, as compared with the preoperative.
And it gradually returned closer to normal at 48h (6-fold; P < 0.
01).
MiR-499 and cTnI exhibited the same trend.
Importantly, miR-499 levels peaked as early as 1 h after declamping, whereas TnI peaked only 6 h after declamping.
Indeed, peak plasma levels of miR-499 correlated significantly with peak level of cTnI (r = 0.
648, P = 0.
001), indicating the degree of myocardial damage.
Conclusions
In this study, we reported the expression of circulating miR-499 in CABG.
In comparison to the preoperative, interestingly, miR-499 plasma levels in patients with CABG up-regulated after the declamping.
Importantly, an outstanding finding in this study is that miR-499 and cTnI exhibited the same trend.
The plasma concentration of miR-499 showed a good correlation with the plasma concentration of cTnI, a classic marker of myocardial injury.
The plasma concentration of miR-499 can be a potential indicator of myocardial injury in CABG.
Thus, our results clearly hold out the hypothesis that miR-499 may be useful for identifying perioperative myocardial injury in CABG patients.
Related Results
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
Objectives
The activation of coagulation and fibrinolysis plays a critical role in the incidence of coronary events. MicroRNAs (miRNAs) are small non-coding ribon...
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Early Onset of Coronary Subclavian Steal Syndrome: A Case Report and Literature Review
Abstract
Introduction
Coronary subclavian steal syndrome (CSSS) is a rare phenomenon that often goes undiagnosed and causes severe complications, including death. This report prese...
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
Abstract
MicroRNAs are a class of non‐coding molecules found to regulate a variety of cellular functions in health and disease. Dysregulation of microRNAs is invo...
Deranged MicroRNA 16-2 Expression Contributes to Erythropoiesis in Polycythemia Vera.
Deranged MicroRNA 16-2 Expression Contributes to Erythropoiesis in Polycythemia Vera.
Abstract
Abstract 3896
Poster Board III-832
We previously reported the finding of significantly raised levels of mature microRNA 16 (mi...
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
MicroRNAs Expression Profile in Young Patients with Acute Myocardial Infarction
Introduction: Acute myocardial infarction (AMI) is a severe coronary heart disease. Targeted miRNAs studies implicated two main pathways in the regulation of AMI namely pro-apopt...
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Abstract
Background
Circulating MicroRNAs (miRNAs) carried by microvesicles (MVs) have various physiological and patholog...
Downregulation of Serum miR-133b and miR-206 Associate with Clinical
Outcomes of Progression as Monitoring Biomarkers for Metastasis
Colorectal Cancer Patients
Downregulation of Serum miR-133b and miR-206 Associate with Clinical
Outcomes of Progression as Monitoring Biomarkers for Metastasis
Colorectal Cancer Patients
Background:
Colorectal cancer (CRC) is the third most common cancer in the world. Non-coding RNAs or microRNAs (miRNAs; miRs) biomarkers can play a role in cancer carcin-ogenesis a...
<b>Circulating MicroRNA Profiles as Early Indicators of Breast Cancer Metastatic Potential</b>
<b>Circulating MicroRNA Profiles as Early Indicators of Breast Cancer Metastatic Potential</b>
Background: Breast cancer outcomes are strongly influenced by metastatic progression, and conventional clinicopathological features may not fully reflect tumor aggressiveness. Circ...

